Wernicke Encephalopathy is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Wernicke encephalopathy is an acute, life-threatening neurological disorder caused by thiamine (vitamin B1) deficiency1. It is most commonly associated with chronic alcohol abuse but can also occur in other conditions causing malnutrition or thiamine malabsorption2.
The study of Wernicke Encephalopathy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Thiamine is an essential cofactor for:
- Alpha-ketoglutarate dehydrogenase (TCA cycle)
- Transketolase (pentose phosphate pathway)
- Pyruvate dehydrogenase (glucose metabolism)
- Thiamine deficiency leads to impaired glucose metabolism
- Accumulation of lactate and reactive oxygen species
- Neuronal death, particularly in vulnerable brain regions
- Mammillary body necrosis (classic finding)
- Periaqueductal gray matter involvement
- Thalamic nuclei damage (particularly dorsomedial nuclei)
- Atrophy of the corpus callosum
- Cerebellar vermis degeneration
- Ophthalmoplegia/nystagmus - Horizontal gaze palsy, vertical nystagmus
- Ataxia - Gait instability, truncal ataxia
- Confusion - Disorientation, impaired consciousness
- Hypothermia
- Hypotension
- Memory disturbances
- peripheral neuropathy
- Chronic alcohol abuse (most common)
- Bariatric surgery
- Hyperemesis gravidarum
- Chronic dialysis
- HIV/AIDS
- Thiamine-deficient diets
- Gastrointestinal disorders causing malabsorption
- Based on history and physical examination
- Response to thiamine supplementation (diagnostic)
- Low thiamine levels (erythrocyte transketolase activity)
- Elevated blood alcohol (in alcohol-related cases)
- Liver function abnormalities
- Electrolyte disturbances
- MRI may show:
- T2/FLAIR hyperintensities in mammillary bodies
- Periaqueductal gray matter
- Thalami
- Cerebellar vermis
- Cranial nerve nuclei
- Histopathological confirmation of lesions
- Intravenous thiamine (500 mg, 3 times daily for 2-3 days)
- Continue high-dose IV thiamine for 5-7 days
- Then oral thiamine maintenance
- Nutritional support
- Correction of electrolyte imbalances
- Treatment of infections
- Management of alcohol withdrawal
- Thiamine supplementation in at-risk populations
- Balanced diet education
- Alcohol abuse treatment
- With early treatment: Good recovery possible
- Delayed treatment: Permanent memory deficits (Korsakoff syndrome)
- Mortality: 10-20% without treatment
- Approximately 80% of survivors develop chronic Korsakoff syndrome
Wernicke encephalopathy and Korsakoff syndrome are often considered a single disease entity (Wernicke-Korsakoff syndrome) because:
- They share the same etiology (thiamine deficiency)
- They often coexist
- Korsakoff syndrome frequently follows untreated Wernicke encephalopathy
Korsakoff syndrome is characterized by:
- Severe anterograde amnesia
- Confabulation
- Executive function deficits
-
Victor, M., et al. (1989). The Wernicke-Korsakoff Syndrome. F.A. Davis Company.
-
Sechi, G., & Serra, A. (2007). Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurology, 6(5), 442-455.
-
Harper, C., et al. (1986). Wernicke's encephalopathy: a prospective necropsy survey. Journal of Neurology, Neurosurgery & Psychiatry, 49(3), 341-345.
-
Thomson, A.D., et al. (2012). Wernicke's encephalopathy: "Plus ça change, plus c'est la même chose". Alcohol and Alcoholism, 47(4), 397-399.
-
Zuccoli, G., & Pipitone, N. (2009). Neuroimaging findings in acute Wernicke's encephalopathy: review of 56 cases. American Journal of Neuroradiology, 30(3), 624-629.
-
Manzo, G., et al. (2014). Wernicke encephalopathy: MR findings at presentation and after follow-up. Radiologia Medica, 119(8), 605-612.
-
[Isenberg-Grzeda, E., et al. (2012). Wernicke-Korsakoff syndrome in non-alcoholic patients: a retrospective cohort study. General Hospital Psychiatry, 34(6), 677-682.](https://pubmed.ncbi.nlm.nih.gov/22871542/)
-
Galvin, R., et al. (2010). EFNS guidelines for the diagnosis, management and treatment of Wernicke encephalopathy. European Journal of Neurology, 17(12), 1408-1418.
-
Chandrakumar, S., et al. (2019). Severe thiamine deficiency in a patient with hyperemesis gravidarum. BMJ Case Reports, 12(9), e230623.
-
Ogershok, P.R., et al. (2002). Wernicke encephalopathy in non-alcoholic patients. American Journal of the Medical Sciences, 323(2), 107-111.